Peptide record

TPDB04152

Dhvar4 Antibacterial Anticancer Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB04152
Dhvar4
Antibacterial Anticancer Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb dbAMP 3.0 i2APP CPPsite3.0 APD_complete HemoPI PD_Hemolysis
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KRLFKKLLFSLRKY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C90H150N24O17
ANDCEQGHIMPTWV
LK
1840.33
11.65
6
0
7
+6
2.14
-0.421
111.43
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
1490
0.81
2
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
4
L
4
K
0
M
2
F
0
P
1
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 4 K: 4 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
14 reviewed residue count
C90H150N24O17 sequence-only estimate (linear, free termini)
1840.33 sequence-only estimate (linear, free termini)
11.65 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
2.14 sequence-only estimate (linear, free termini)
-0.421 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Cationic Activity
Linear Activity
Free Activity
Evidence Records 40 records
Evidence 1 Activity

Activity

MIC
Antibacterial
250 µg/mL

Target

C.albicans 315 or B311 or resistant

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against fungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7
Evidence 2 Activity

Activity

MIC
Antibacterial
250 µg/mL

Target

C.glabrata 359

Source & Reference

dbAMP DRAMP

Other

Active against fungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807
Evidence 3 Activity

Activity

MIC
Antibacterial
62.5 µg/mL

Target

C. krusei 355

Source & Reference

dbAMP DRAMP

Other

ungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof
Evidence 4 Activity

Activity

MIC
Antibacterial
7.8 µg/mL

Target

C. neoformans 316

Source & Reference

dbAMP DRAMP

Other

esistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof et al., 2000 ). Also active against
Evidence 5 Activity

Activity

MIC
Antibacterial
250 µg/mL

Target

A.fumigatus X 807219

Source & Reference

dbAMP DRAMP

Other

9 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof et al., 2000 ). Also active against prosthetic microorganisms, including C. t
Evidence 6 Activity

Activity

MIC
Antibacterial
16 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

9/6, S. mucilaginosus GB 16/3, E. faecium 603, E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16
Evidence 7 Activity

Activity

MIC
Antibacterial
8 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

B 16/3, E. faecium 603, E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (
Evidence 8 Activity

Activity

MIC
Antibacterial
16 µM

Target

M. luteus

Source & Reference

dbAMP DRAMP

Other

E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al
Evidence 9 Activity

Activity

MIC
Antibacterial
32 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

ing et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 10 Activity

Activity

MIC
Antibacterial
16 µM

Target

P. vulgaris

Source & Reference

dbAMP DRAMP

Other

. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 11 Activity

Activity

MIC
Antibacterial
32 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

ilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 12 Activity

Activity

MIC
Antifungal
250 µg/mL

Target

C.albicans 315 or B311 or resistant

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against fungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7
Evidence 13 Activity

Activity

MIC
Antifungal
250 µg/mL

Target

C.glabrata 359

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against fungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807
Evidence 14 Activity

Activity

MIC
Antifungal
62.5 µg/mL

Target

C. krusei 355

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof
Evidence 15 Activity

Activity

MIC
Antifungal
7.8 µg/mL

Target

C. neoformans 316

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

esistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof et al., 2000 ). Also active against
Evidence 16 Activity

Activity

MIC
Antifungal
250 µg/mL

Target

A.fumigatus X 807219

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

9 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof et al., 2000 ). Also active against prosthetic microorganisms, including C. t
Evidence 17 Activity

Activity

MIC
Antifungal
16 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

9/6, S. mucilaginosus GB 16/3, E. faecium 603, E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16
Evidence 18 Activity

Activity

MIC
Antifungal
8 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

B 16/3, E. faecium 603, E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (
Evidence 19 Activity

Activity

MIC
Antifungal
16 µM

Target

M. luteus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al
Evidence 20 Activity

Activity

MIC
Antifungal
32 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ing et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 21 Activity

Activity

MIC
Antifungal
16 µM

Target

P. vulgaris

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 22 Activity

Activity

MIC
Antifungal
32 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 23 Activity

Activity

MIC
Antiparasitic
250 µg/mL

Target

C.albicans 315 or B311 or resistant

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against fungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7
Evidence 24 Activity

Activity

MIC
Antiparasitic
250 µg/mL

Target

C.glabrata 359

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against fungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807
Evidence 25 Activity

Activity

MIC
Antiparasitic
62.5 µg/mL

Target

C. krusei 355

Source & Reference

dbAMP 3.0 DRAMP

Other

ungi C.albicans 315 or B311 or resistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof
Evidence 26 Activity

Activity

MIC
Antiparasitic
7.8 µg/mL

Target

C. neoformans 316

Source & Reference

dbAMP 3.0 DRAMP

Other

esistant (MIC 250 ug/ml), C.glabrata 359 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof et al., 2000 ). Also active against
Evidence 27 Activity

Activity

MIC
Antiparasitic
250 µg/mL

Target

A.fumigatus X 807219

Source & Reference

dbAMP 3.0 DRAMP

Other

9 (MIC 250 ug/ml), C. krusei 355 (MIC 62.5 ug/ml), C. neoformans 316 (MIC 7.8 ug/ml), and A.fumigatus X 807219 (MIC 250 ug/ml) ( van't Hof et al., 2000 ). Also active against prosthetic microorganisms, including C. t
Evidence 28 Activity

Activity

MIC
Antiparasitic
16 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP

Other

9/6, S. mucilaginosus GB 16/3, E. faecium 603, E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16
Evidence 29 Activity

Activity

MIC
Antiparasitic
8 µM

Target

B. subtilis

Source & Reference

dbAMP 3.0 DRAMP

Other

B 16/3, E. faecium 603, E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (
Evidence 30 Activity

Activity

MIC
Antiparasitic
16 µM

Target

M. luteus

Source & Reference

dbAMP 3.0 DRAMP

Other

E. coli at 4 ug/mL( Elving et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al
Evidence 31 Activity

Activity

MIC
Antiparasitic
32 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

ing et al., 2000 ). S. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 32 Activity

Activity

MIC
Antiparasitic
16 µM

Target

P. vulgaris

Source & Reference

dbAMP 3.0 DRAMP

Other

. aureus (MIC 16 uM), B. subtilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 33 Activity

Activity

MIC
Antiparasitic
32 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP 3.0 DRAMP

Other

ilis (MIC 8 uM), M. luteus (MIC 16 uM), E. coli (MIC 32 uM), P. vulgaris (MIC 16 uM), and P. aeruginosa (MIC 32 uM) ( Yang et al., 2023 .
Evidence 34 Activity

Activity

Cell-penetrating Peptides

Target

Monomac6 Human Monocytes

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Non-natural residues Linear L Cationic
Protein derived
Cellular uptake slightly affected by CF-labelling
In vitro
Evidence 35 Activity

Activity

50% Hemolysis
Toxicity
42±12 µM
Hemolytic Cytotoxic
50% Hemolysis | 42±12 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 36 Activity

Activity

50% Hemolysis
Toxicity
58±2.0 µM
Hemolytic Cytotoxic
50% Hemolysis | 58±2.0 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 37 Activity

Activity

50% Hemolysis
Toxicity
35±3.0 µM
Hemolytic Cytotoxic
50% Hemolysis | 35±3.0 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 38 Activity

Activity

50% Hemolysis
Toxicity
23±2.0 µM
Hemolytic Cytotoxic
50% Hemolysis | 23±2.0 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 39 Activity

Activity

50% Hemolysis
Toxicity
>109 µM
Hemolytic Cytotoxic
50% Hemolysis | >109 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 40 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.